Patent intelligence · CN
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI co…
Patent details — CN 119343336
- Jurisdiction
- CN
- Status
- granted
- Grant date
- Jan 21, 2025
- Expiration
- Jan 16, 2045
- Applicant
- BRACCO IMAGING SPA
- CPC classes
- A61K 49/ 10 A I, A61K/49106
Quick answer
CN 119343336 (1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents) is held by BRACCO IMAGING SPA. Status: granted. Granted Jan 21, 2025. Expires Jan 16, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BRACCO IMAGING SPA
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 49/ 10 A I, A61K/49106
More from BRACCO IMAGING SPA
Related pharmaceutical patents in our USPTO index.
-
CN 119365549
Fluorescent probe targeting CA-IX
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
이량체 조영제의 제조
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
가도테리돌 제조를 위한 제조 방법
granted
Frequently asked questions
What is US patent 119343336?
CN 119343336 (1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents) is held by BRACCO IMAGING SPA. Status: granted. Granted Jan 21, 2025. Expires Jan 16, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CN 119343336?
BRACCO IMAGING SPA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CN 119343336 expire?
Our index shows an expiration date of Jan 16, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.